Cargando…
Metabolic Plasiticy in Cancers—Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs
Research on cancer metabolism has recently re-surfaced as a major focal point in cancer field with a reprogrammed metabolism no longer being considered as a mere consequence of oncogenic transformation, but as a hallmark of cancer. Reprogramming metabolic pathways and nutrient sensing is an elaborat...
Autores principales: | Ždralević, Maša, Marchiq, Ibtissam, de Padua, Monique M. Cunha, Parks, Scott K., Pouysségur, Jacques |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742324/ https://www.ncbi.nlm.nih.gov/pubmed/29326883 http://dx.doi.org/10.3389/fonc.2017.00313 |
Ejemplares similares
-
Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
por: Marchiq, Ibtissam, et al.
Publicado: (2015) -
Editorial: Immunometabolism and therapeutic targeting of aggressive cancers
por: Ždralević, Maša, et al.
Publicado: (2023) -
Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer
por: Cassim, Shamir, et al.
Publicado: (2020) -
Disrupting glucose-6-phosphate isomerase fully suppresses the “Warburg effect” and activates OXPHOS with minimal impact on tumor growth except in hypoxia
por: de Padua, Monique Cunha, et al.
Publicado: (2017) -
Knock out of the BASIGIN/CD147 chaperone of lactate/H+ symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction
por: Marchiq, Ibtissam, et al.
Publicado: (2015)